Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017231 | SCV005643375 | uncertain significance | Arthrogryposis, renal dysfunction, and cholestasis 1; Keratoderma-ichthyosis-deafness syndrome, autosomal recessive; Cholestasis, progressive familial intrahepatic, 12 | 2024-02-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004732156 | SCV005338853 | uncertain significance | VPS33B-related disorder | 2024-05-06 | no assertion criteria provided | clinical testing | The VPS33B c.1180A>G variant is predicted to result in the amino acid substitution p.Ile394Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |